Baricitinib for Prurigo Nodularis: A Pilot Study on Efficacy and Safety

Table 2

Outcomes (N = 12).

Outcomes, mean ± SD	Time
	Baseline	Day 2	Day 4	Week 1	Week 2	Week 4	Week 8	Week 12
Pruritus score	8.67 ± 1.37	3.67 ± 1.83	2.92 ± 2.15	2.42 ± 2.11	1.58 ± 1.17	1.00 ± 0.60	0.50 ± 0.67	0.33 ± 0.49
Sleep score	6.25 ± 1.87	8.42 ± 1.00	8.25 ± 1.49	8.75 ± 1.29	9.00 ± 1.04	9.25 ± 0.62	9.50 ± 1.00	9.75 ± 0.62
No. of nodules	84.12 ± 28.59	NA	NA	76.17 ± 31.60	47.33 ± 31.60	30.67 ± 32.41	13.50 ± 21.22	10.75 ± 21.32
DLQI	13.00 ± 6.41	NA	NA	6.08 ± 3.99	3.17 ± 2.55	2.25 ± 1.69	1.00 ± 1.21	0.92 ± 1.00
IGA	7.17 ± 0.72	NA	NA	5.33 ± 1.16	3.83 ± 1.19	3.25 ± 1.49	2.25 ± 1.66	1.33 ± 1.37